GenomIdea Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 17
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

GenomIdea General Information

Description

Developer of novel therapeutic drugs. The company's novel therapeutic drugs include anti-cancer drugs, nucleic acid medicines and DNA vaccines, enabling patients to reduce their cancer and other infectious diseases more effectively.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 4F, Saito Bio-Incubator, 7-7-15
  • Saito-asagi, Ibaraki
  • Osaka, 567-0085
  • Japan
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GenomIdea Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GenomIdea‘s full profile, request access.

Request a free trial

GenomIdea Executive Team (1)

Name Title Board Seat Contact Info
Toshihiro Nakajima President & Chief Executive Officer
To view GenomIdea’s complete executive team members history, request access »

GenomIdea Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenomIdea Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GenomIdea‘s full profile, request access.

Request a free trial